The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
morpholino(4-((6-(4-(propylsulfonyl)piperazin-1-yl)pyridin-3-yloxy)methyl)piperidin-1-yl)methanone ID: ALA1089838
PubChem CID: 46885049
Max Phase: Preclinical
Molecular Formula: C23H37N5O5S
Molecular Weight: 495.65
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCS(=O)(=O)N1CCN(c2ccc(OCC3CCN(C(=O)N4CCOCC4)CC3)cn2)CC1
Standard InChI: InChI=1S/C23H37N5O5S/c1-2-17-34(30,31)28-11-9-25(10-12-28)22-4-3-21(18-24-22)33-19-20-5-7-26(8-6-20)23(29)27-13-15-32-16-14-27/h3-4,18,20H,2,5-17,19H2,1H3
Standard InChI Key: PNLYWRXTTZTKPC-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 37 0 0 0 0 0 0 0 0999 V2000
17.4527 -12.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4516 -13.5898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1664 -14.0027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8828 -13.5894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8800 -12.7588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1646 -12.3497 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7343 -12.3457 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7361 -11.5197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0257 -11.1075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3089 -11.5167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.3071 -12.3426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0221 -12.7594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5980 -14.0007 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.3118 -13.5871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0269 -13.9985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0241 -14.8215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7351 -15.2328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4514 -14.8227 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.4521 -13.9968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7365 -13.5809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1650 -15.2368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1631 -16.0618 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.8803 -14.8259 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.5959 -11.1016 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.8799 -11.5116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0083 -10.5125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1792 -10.5125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1669 -11.0966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4510 -11.5065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4489 -16.4690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4451 -17.2904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1568 -17.7083 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.8740 -17.2986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8795 -16.4710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 5 1 0
2 3 1 0
5 6 2 0
15 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
7 12 1 0
18 21 1 0
8 9 1 0
21 22 1 0
9 10 1 0
21 23 2 0
10 11 1 0
10 24 1 0
11 12 1 0
24 25 1 0
1 7 1 0
24 26 2 0
6 1 1 0
24 27 2 0
4 13 1 0
25 28 1 0
7 8 1 0
28 29 1 0
22 30 1 0
13 14 1 0
1 2 2 0
14 15 1 0
15 16 1 0
3 4 2 0
22 34 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 495.65Molecular Weight (Monoisotopic): 495.2515AlogP: 1.49#Rotatable Bonds: 7Polar Surface Area: 95.52Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.73CX LogP: 0.51CX LogD: 0.50Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.57Np Likeness Score: -2.01
References 1. Wu Y, Kuntz JD, Carpenter AJ, Fang J, Sauls HR, Gomez DJ, Ammala C, Xu Y, Hart S, Tadepalli S.. (2010) 2,5-Disubstituted pyridines as potent GPR119 agonists., 20 (8): [PMID:20227877 ] [10.1016/j.bmcl.2010.02.083 ]